Supramolecular cancer nanotheranostics

Author:

Zhou Jiong12345ORCID,Rao Lang678910,Yu Guocan678910ORCID,Cook Timothy R.311121314ORCID,Chen Xiaoyuan15161717ORCID,Huang Feihe12345ORCID

Affiliation:

1. State Key Laboratory of Chemical Engineering

2. Center for Chemistry of High-Performance & Novel Materials

3. Department of Chemistry

4. Zhejiang University

5. Hangzhou 310027

6. Laboratory of Molecular Imaging and Nanomedicine

7. National Institute of Biomedical Imaging and Bioengineering

8. National Institutes of Health

9. Bethesda

10. USA

11. University at Buffalo

12. The State University of New York

13. Buffalo

14. New York 14260-3000

15. Departments of Diagnostic Radiology, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering

16. National University of Singapore

17. Singapore

Abstract

Supramolecular cancer nanotheranostics have shown promising potentials in early-stage diagnosis and personal therapy. Herein, we summarize the progress of supramolecular cancer nanotheranostics and provide guidance for designing new targeted supramolecular theranostic agents.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Fundamental Research Funds for the Central Universities

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Cited by 303 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3